Notably, SMBVs can also deliver oligonucleotides within cells to improve cancer therapies based on antisense nucleic acid which inhibit expression of oncogenes. An antisense ODN was designed to inhibit erbB-2 mRNA translation then tested in two cell models overexpressing the proto-oncogene protein P18...